Gary D. Novack

Dr. Novack provides regulatory affairs oversight for the company, and is a board-certified clinical pharmacologist specializing in ophthalmology. He has over 40 years of pharmaceutical industry experience, and has provided critical roles in the development and approval of over 50 products. He has authored nearly 300 publications and serves on several editorial boards for ophthalmic journals. Dr. Novack is also a Clinical Professor of Ophthalmology at the University of California, Davis School of Medicine, Chaired the 2017 Clinical Trials and Regulatory sub-committee of the Dry Eye Workshop II, and was a Regent of the University of California. He earned his PhD in Pharmacology and Environmental Toxicology from the University of California, Davis and completed a post-doctoral fellowship in Neurophysiology at the University of California, Los Angeles.